Infantile osteopetrosis; bone marrow transplantation from a cousin donor

Area of Science:

• Pediatric Hematology
• Immunogenetics
• Bone Marrow Transplantation

Background:

• Infantile osteopetrosis is a rare genetic disorder characterized by impaired osteoclast function, leading to bone density abnormalities.
• Bone marrow transplantation (BMT) is a potential curative treatment for infantile osteopetrosis, aiming to replace defective hematopoietic stem cells.
• Human Leukocyte Antigen (HLA) matching between donor and recipient is crucial for successful engraftment and minimizing graft-versus-host disease.

Observation:

• A case study of an Asian child with infantile osteopetrosis undergoing BMT from an HLA-A,B matched cousin donor.
• Retrospective HLA molecular analysis identified a specific incompatibility at the HLA-DPB1 locus between the patient and donor.
• Post-transplantation monitoring confirmed the presence of donor-derived cells in the patient, indicating successful engraftment.

Findings:

• The BMT procedure resulted in the successful correction of infantile osteopetrosis.
• Engraftment occurred despite a known HLA-DPB1 mismatch, suggesting potential tolerance or alternative mechanisms of successful BMT.
• The patient is alive and in good health following the transplantation.

Implications:

• This case highlights the potential for successful BMT in infantile osteopetrosis even with certain HLA incompatibilities.
• Further research may explore the impact of specific HLA locus mismatches on BMT outcomes in osteopetrosis.
• The findings contribute to understanding HLA compatibility requirements and donor selection strategies for BMT in rare pediatric diseases.